ArticleSERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
ArticleSERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
ArticleCirculating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity
ArticleCirculating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleSerum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.
ArticleSerum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.
ArticleAssociation between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati
ArticleAssociation between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati
ArticleEVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS
ArticleEVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS